AI-generated summary
In two controlled rat studies, the authors examined whether low-level laser therapy could modulate TNFalpha levels during acute lung injury induced by an antigen challenge. They report that a 650-nm laser dose of 0.11 Joules significantly reduced TNFalpha levels compared with controls, and that the effect appeared to depend on the dose used.
- Participants
- 35
- Who or what was studied
- Male Wistar rats with antigen-induced acute lung injury
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The study was conducted in rats with induced acute lung injury, so the findings may not apply to human inflammatory conditions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Dose, Inflammation, Confidence interval, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.